Skip to main content
Tech.euFundingExplorerBeta

BrightHeart

Medical technology company developing artificial intelligence software focused on improving the detection of congenital heart defects in fetuses

BrightHeart has raised €13M across 2 funding rounds from 11 investors, most recently a Series A round in Jan 2026. Based in Paris, France; active in Healthtech. Data as of 28 Oct 2026.

Total raised
€13M
€13,000,000
Funding rounds
2
Investors
11
distinct backers
Active since
2023-05
latest 2026-01

Funding by year

EUR raised per year · 2026 YTD
BrightHeart — funding by year — interactive chart.
Data table
BrightHeart — funding by year
2023€2.0M
2026€11M

Signals

High confidence
Raise-next likelihood52
base rate 44% for Series A
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood16
base rate 11% (2+ rounds)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

2 rounds
DateStageAmountInvestors
2026-01-08Series A€11MAngel Investors,Go Capital,IDAHO HealthTech Club,John Gridley,Lift Value,Mussallem CHD Alliance+5 moreView deal →
2023-05-31Seed€2.0MSofinnova PartnersView deal →

Related news

Similar companies

same sector or country

Global coverage: FundingData